2008
DOI: 10.1088/0957-4484/19/36/365603
|View full text |Cite
|
Sign up to set email alerts
|

Highly water-dispersible PEG surface modified ultra small superparamagnetic iron oxide nanoparticles useful for target-specific biomedical applications

Abstract: For the application of superparamagnetic iron oxide nanoparticles in biomedical fields for target-specific purposes, they should be ultra small in diameter. We developed a simple one-step synthesis of surface modified ultra small superparamagnetic iron oxide nanoparticles (USPIONs) with an average particle diameter of 1.7 nm in a polar organic solvent. Polyethylene glycol diacid (PEG) surface modified USPIONs synthesized in triethylene glycol were nearly monodisperse in diameter and highly water-dispersible. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
97
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 129 publications
(103 citation statements)
references
References 30 publications
6
97
0
Order By: Relevance
“…Ultra-small superparamagnetic iron oxide nanoparticles (USPIONs) also act as T 1 contrast agents. Park et al (2008) reported the synthesis of polyethylene-glycol-capped iron oxide nanoparticles which act both as T 1 and T 2 contrast agents. The corresponding relaxivities r 1 and r 2 have been reported as 4.46 and 15.01 mM -1 s -1 in a magnetic field of 1.5 T. Blood residence time of nanoparticles is known to increase with decreasing particle size (Arruebo et al 2007) and larger particles are rapidly absorbed by the reticuloendothelial system and accumulated in the liver or spleen preventing their availability in the blood.…”
Section: Introductionmentioning
confidence: 99%
“…Ultra-small superparamagnetic iron oxide nanoparticles (USPIONs) also act as T 1 contrast agents. Park et al (2008) reported the synthesis of polyethylene-glycol-capped iron oxide nanoparticles which act both as T 1 and T 2 contrast agents. The corresponding relaxivities r 1 and r 2 have been reported as 4.46 and 15.01 mM -1 s -1 in a magnetic field of 1.5 T. Blood residence time of nanoparticles is known to increase with decreasing particle size (Arruebo et al 2007) and larger particles are rapidly absorbed by the reticuloendothelial system and accumulated in the liver or spleen preventing their availability in the blood.…”
Section: Introductionmentioning
confidence: 99%
“…Magnetic nanoparticles with tailored surface chemistry have recently attracted a great deal of attention by virtue of their potential biomedical applications including magnetic resonance imaging (MRI) contrast enhancement [1][2][3][4], hyperthermia [5][6][7], immunoassay [8], and drug delivery [9]. Hyperthermia involves applying an alternating magnetic field of suitable frequency that produces heat dissipation through the oscillation of the internal magnetic moment of superparamagnetic particles.…”
Section: Introductionmentioning
confidence: 99%
“…These are consistent with expectations because the d mag corresponds to the largest nanoparticle in a size distribution. As provided in Table I, net magnetizations in both samples were smaller than 6.5 and 8.4 emu/g of ultra small iron oxide nanoparticles 17 and ultra small gadolinium oxide nanoparticles, 18 respectively. Therefore, magnetization was reduced by doping Gd(III) into ultra small iron oxide nanoparticles.…”
Section: Magnetic Propertiesmentioning
confidence: 90%
“…Figure 9 clearly shows Gd(III) doping effect on magnetization and r 1 and r 2 values. That is, magnetizations and r 1 and r 2 values of two samples are smaller than those of ultra small iron oxide nanoparticles 17 and ultra small gadolinium oxide nanoparticles. 18 As investigated by others, magnetic moment of Gd(III) is anti-parallel to net magnetic moment of Fe(III)/Fe(II) in oxides.…”
Section: Magnetic Propertiesmentioning
confidence: 92%
See 1 more Smart Citation